INTERNATIONAL PATENT: FORTVITA BIOLOGICS (SINGAPORE) PTE. LTD., 福佑泰生物制药（新加坡）公司 FILES APPLICATION FOR "METHOD OF USING CLAUDIN18.2-TARGETED ANTIBODY-DRUG CONJUGATE IN COMBINATION THERAPY FOR CANCER"

GENEVA, April 19 -- FORTVITA BIOLOGICS (SINGAPORE) PTE. LTD. (38 Beach Road #29-11 South Beach TowerSingapore 189767), 福佑泰生物制药（新加坡）公司 (新加坡新加坡市美芝路38号南海滩大厦#29-11) filed a patent application (PCT/CN2024/124096) for "METHOD OF USING CLAUDIN18.2-TARGETED ANTIBODY-DRUG CONJUGATE IN COMBINATION THERAPY FOR CANCER" on Oct 11, 2024. With publication no. WO/2025/077815, the details related to the patent application was published on Apr 17, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) s...